Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies

Glioblastoma (GBM) is an aggressive brain malignancy with a dismal prognosis. With emerging evidence to disprove brain-immune privilege, there has been much interest in examining immunotherapy strategies to treat central nervous system (CNS) cancers. Unfortunately, the limited success of clinical st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Ratnam, Nivedita M., Sonnemann, Heather M., Frederico, Stephen C., Chen, Huanwen, Hutchinson, Marsha-Kay N. D., Dowdy, Tyrone, Reid, Caitlin M., Jung, Jinkyu, Zhang, Wei, Song, Hua, Zhang, Meili, Davis, Dionne, Larion, Mioara, Giles, Amber J., Gilbert, Mark R.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8320893/
https://ncbi.nlm.nih.gov/pubmed/34336705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.719091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados